• Further information regarding the offer to purchase shares by Redmile Group LLC

    Read more
  • Appointment of Non-Executive Director and changes to Board committees

    Read more
  • Redx signs out licensing agreement with AstraZeneca

    Read more
  • Result of General Meeting

    Read more
  • Proposed financing of $30 million via issue of convertible loan notes and share subscription and notice of General Meeting

    Read more
  • Interim results for the six months ended 31 March 2020

    Read more
  • New All Employee Share Option Scheme and Grant of Options

    Read more
  • Redx Pharma PLC’s Lisa Anson updates on lead asset RXC004 and increased investment by Redmile

    Read more
  • Change of Adviser

    Read more
  • Appointment of Non-Executive Director with Deep Experience of the Biotechnology Industry and Capital Markets

    Read more